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Summary
Objectives To establish whether the provision of numerical data using
pictograms and framed as event rates affects subjects’ attitudes to
colorectal cancer (CRC) screening.
Design Randomized questionnaire and telephone study comparing a
control group given standard NHS CRC information leaﬂets with an
intervention group given the same leaﬂet but enhanced with additional
numerical and pictorial information.
Setting District General hospital and two general practices in North
East England. Study carried out immediately prior to the introduction of
CRC screening.
Participants A total of 478 non-gastroenterological subjects (age
range 60–70 years).
Main outcome measures The difference in the two groups’ overall
wish to bescreened;comparison ofthe impactof enhanced vs.unenhanced
summarypointsintheNHSinformationleaﬂet;thesummarypointthatmost
inﬂuenced their decision on screening; the views of the intervention group
on the additional numerical and pictorial information provided.
Results A total of 256 (54%) responded (124 from the control group and
117 from the intervention group); 22% were interviewed by telephone; 90%
of the control group and 85% of the intervention group wished to be
screened (P=0.34). Provision of numerical and pictorial information
signiﬁcantly changed the impact of ﬁve of the six summary points on the
decision to be screened. Sixty-two percent of the intervention group found
the pictograms helpful while 83% of those interviewed by telephone found
the numerical data helpful; 73% of the control group when given by
telephone the additional numerical information given to the intervention
group said this would have been useful in aiding their decision-making.
Conclusion Providing additional numerical information would enhance
the credibilityof the screening programme without necessarily reducing the
numbers screened.
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RESEARCH
1‘How well we communicate is determined not by
how well we say things but how well we are under-
stood.’ Andrew Grove, co-founder of Intel
1
Introduction
Four large randomized controlled trials have
shown that biennial guaiac-based faecal occult
blood testing (GFOBT) reduces colorectal cancer
(CRC) mortality by 16% in the population tested
and in the UK has the potential to save over 1000
deaths from CRC each year.
2–6 The Minnesota
group further demonstrated that the incidence of
CRC (as opposed to the mortality) was reduced
by continued involvement in the screening study
but only 18 years after commencement of colono-
scopic surveillance, the presumed mechanism
being removal of pre-cancerous polyps in the
screened group.
7 More recently a reduction in
CRC incidence and mortality at 12 years has
been demonstrated using one-off ﬂexible sigmoi-
doscopy.
8 GFOBT, followed by colonoscopy if
positive, is the current method used for
CRC screening in the UK initially offered to
60–70-year-olds, with the age range nowextended
to 75 years.
As with all screening tools the ﬁgures are posi-
tive in terms of population beneﬁt, but the beneﬁt
(and risk) to the individual and the individual’s
perception of that beneﬁt and risk is less clear-cut,
partly because of the lack of sensitivity and speci-
ﬁcity of the screening process and partly because
the majority screened will not develop CRC
whether screened or not. Thus GFOBT has low
sensitivity for advanced neoplasia of around
20% and as low as 13% in one study
9 and in clini-
cal trials half of cancers are missed by biennial
stool testing.
10 The chance of an individual bene-
ﬁting from screening through prevention of
death from CRC is estimated at 1 in 862.
11 No
overall mortality advantage has been shown in
those screened, and is unlikely to be, as the screen-
ing trials target a disease that contributes a life-
time risk of only 3% to all-cause mortality
11 and
screening seeks only to reduce this risk in those
already with precursor lesions or cancer arising
in the screened age group. Assuming no untoward
consequences of the screening intervention, this
amounts to less than 1/2% mortality reduction
(16% of 3%). No study has been powered to
detect such small reductions in mortality. Further-
more the risk of a serious adverse effect such as
haemorrhage or perforation in those undergoing
colonoscopy, of whom only 10% will have
cancer, is around 1 in 150.
12,13 The current advice
leaﬂet inviting UK subjects to partake in the
CRC screening programme focuses on population
beneﬁt but does not place CRC mortality in the
context of all-cause mortality
12 and the absence
of this and other patient-focused data lays the
CRC programme open to the same adverse publi-
city surrounding the UK breast cancer screening
programme.
14 A Cochrane review of trials of
decision aids showed that decision aids enhanced
risk perceptions and the effect was stronger when
probabilitieswere expressedquantitatively.
15Inthis
study we have compared the attitudes to screening
of a control cohort, given the standard NHS infor-
mation leaﬂet, to the attitudes of an intervention
group given the same information leaﬂet but
enhanced with numerical data expressed in
natural frequency format, percentages, information
on prolongation of life and pictograms all aimed at
the risks and beneﬁts to the individual rather than
the population as it is on the individual that the
burden of decision-making falls.
Patients and methods
The study was conducted in 2008 shortly before
the introduction of CRC screening in our
area. Subjects were recruited from patients
between the age of 60 and 69 attending non-
gastroenterology hospital medical clinics and
patients attending two GP surgeries. Subjects
were excluded if they presented with or had gas-
troenterological problems, had previous colon
cancer, terminal or advanced disease with
limited life expectancy, or previously had a
colonoscopy.
Those consenting to take part were randomized
to receive one of two information packs using
computer-generated pseudo-random numbers,
uniformly distributed between 0 and 1 with allo-
cation determined by whether the number was
less than or greater than 0.5. Information packs
were concealed in these randomly numbered
plain envelopes with researchers and study coor-
dinators blinded to their contents. The control
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Reviewer
Karsten Jo /rgensengroup received the standard NHS information
leaﬂet given to subjects invited to take part in
CRC screening including the six summary points
contained in the leaﬂet (Figure 1).
12 The interven-
tion group were given the same information but
with the summary points augmented with
numerical information taken from the four ran-
domized studies of CRC screening and a
meta-analysis of all studies (Figure 2).
2–7,11 and
supplemented with pictorial information to illus-
trate three of the six summary points. The
enhanced information pack was based on
Paling’s risk charts and was tested and reﬁned on
a group of 30 subjects before starting the trial. A
format of events per 10,000 subjects was used to
illustrate with the same denominator low fre-
quency events such as complications of colono-
scopy and high frequency events such as overall
mortality at 12 years. The intervention pack con-
tained two additional numerical facts not present
in the summary of the standard pack: (1) ‘nine
out of ten patients with positive occult blood
tests do not have cancer’; and (2) ‘screening does
not affect overall mortality’. The overall mortality
ﬁgures were illustrated with a pictogram
(Figure 2).
Subjects were asked to read the information leaf-
lets at home and return a questionnaire asking, on
the basis of the information received, whether or
not they would wish to be screened for CRC and
which of the summary points had most inﬂuenced
their decision. For each summary point subjects
were asked whether this made them: ‘deﬁnitely
want to be screened’; ‘want to be screened’; ‘not
want to be screened’; or ‘deﬁnitely not want to be
screened’. Free-text comments were invited. The
questionnaire included questions on demographic
data and co-morbidities and subjects were asked
their attitude to screening in general. Those failing
to return questionnaires within three weeks were
sent one reminder.
One-quarterof subjects returning theirquestion-
naire were chosen at random to be interviewed by
telephone. The interviewer went through the ques-
tionnaire point by point, grading for each point
whetherthatpointshadbeenunderstoodfully,par-
tially or not at all. In addition, control subjects were
given by telephone the same numerical infor-
mation that had been given to the intervention
group and asked whether having these ﬁgures at
the onset would have helped theirdecision-making
process or altered their ﬁnal decision.
We had assumed that, as in national studies,
there would be a 50% acceptance of screening and
so would need 120 subjects in each group to give
an 85% probability of detecting a 20% difference
between the two groups, with a two-sided test at
the 5% level. Statistical analysis of differences
between proportions was carried out using the two-
tailed chi-squared test without the Yates correction.
The study was approved by the NHS Research
Ethics Committee (07/H0905/56, July 2007).
Results
A total of 478 questionnaires were given out of
which 256 were returned (54%). Fifteen returns
were excluded (age >70 years or <60 years, pre-
vious colonoscopy, history of colon cancer or
incompletely ﬁlled in forms) leaving 124 subjects
in the control group and 117 in the intervention
group.
There was no signiﬁcant difference in mean
age, smoking prevalence or presence of
Figure 1
Information shown to the control group, as in the standard NHS
information pack
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3co-morbidities between the groups. However sub-
jects in the intervention group were more likely to
have a relative with bowel cancer than those in the
control group (15% v 31%, P= 0.02) (Table 1).
Additional numerical and pictorial information
given to the intervention group did not affect their
overall decision on whether or not to be screened:
90% in the control group and 85% in the interven-
tion group said they would wish to take part in
bowel cancer screening (χ
2 =0.92, P =0.34).
However, there was a decrease in the impact of
three of the summary points inﬂuencing decision-
making when numerical and pictorial information
were provided (Table 2). Thus the percentage of
subjects who said that that Point 1 made them
‘deﬁnitely want to be screened’ fell from 61% of
the control group who were told ‘Taking part in
the cancer screening programme reduces your
chance of dying from bowel cancer’, to 41% (P =
0.002) in the intervention group when informed
by text and pictogram that: ‘The screening pro-
gramme will prevent 12 people [per 10,000], that
is 1 in every 862 screened, from dying of bowel
cancer’.
When the small risk of colonoscopy compli-
cation was illustrated graphically the numbers
who said this made them not want to be screened
or deﬁnitely not want to be screened increased
Figure 2
Information shown to the intervention group containing the information shown to the control group embellished with
additional numerical information and pictograms
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4from 11% to 24% (P= 0.006) and a similar increase
(7% to 19%, P= 0.008) was seen when subjects
were told that half of CRC cancers may be
missed by the screening programme (Table 2).
Conversely, in the intervention group the infor-
mation that ‘Not all bowel cancers detected by
screening can be successfully treated. If you are
found to have bowel cancer through screening,
you will live on average 1.1 years longer than if
you waited until your bowel cancer presented
with symptoms’ had a positive impact on screen-
ing intention compared to the information given
to the control group who were only told: ‘not all
bowel cancers detected by screening can be suc-
cessfully treated’: 39% in the intervention group
vs. 26% in the control group said this point
would deﬁnitely make them want to be screened
(P =0.035) and there was a halving of those who
said this point had no impact (Table 2).
There was also a difference in the summary
point which subjects felt had most inﬂuenced
their overall decision on whether or not to be
screened: 65% of those in the control group said
the information contained in summary point 1
(taking part in the CRC screening programme
can reduce your chance of dying from bowel
cancer) was the most important point in helping
them reach their decision compared to 40% in
the intervention group (P= 0.0001), while polyp
detection was seen as the most important
summary point by more subjects in the interven-
tion group compared to the control group (21% v
7%, respectively; P =0.0006) (Table 3).
In their questionnaire responses, 62% of the
intervention group found the pictograms helpful
(23% very helpful and 39% quite helpful) while
34%found them unhelpfuland4% veryunhelpful.
Fifty-seven subjects were interviewed by tele-
phone. Of the 33 in the control group 73% said
the additional numerical information given to
the intervention group would have been useful
to them in coming to their decision. One subject
said that knowledge of these ﬁgures would have
reversed his decision on whether to be screened.
Of the 24 subjects in the intervention group who
were interviewed by telephone, 83% said the
numerical data were useful and felt it had inﬂu-
enced their decision-making. In the intervention
group one subject was judged to have poor under-
standing of all of the summary points, the remain-
der were judged to have full understanding. In the
control group one was judged to have poor under-
standing, one partial understanding, and the
remainder full understanding of the summary
points under test.
Discussion
Statement of principal ﬁndings
Our study suggests that provision of numerical
and pictorial data does not inﬂuence subjects’
overall desire to be screened but does inform
their decision-making process. Thus a signiﬁcant
Table 1
Demographic information and co-morbidities in
control and intervention group
Control
group
(n =124)
Intervention
group (n =117)
Women (%) 55.2 40.8
Mean age (years) 64.8±3.1 64.7±3.3
Retired (%) 74.8 76.7
Current smokers
(%)
10.0 10.4
Ex-smokers (%) 46.7 50.4
Never smoked (%) 43.3 39.1
Co-morbidities (%)
Hypertension 48.8 41.4
Diabetes mellitus 17.9 20.7
Ischaemic heart
disease
26.0 19.0
Bronchitis 2.4 1.7
Indigestion 22.8 13.8
Asthma 13.8 8.6
Kidney disease 3.3 0.9
Others 35.8 31.0
Family history of
CRC (%)
14.6 31.0
Friend’s history of
CRC (%)
29.4 21.9
Attitude to
screening (%)
Positive 82.8 77.0
Neutral 13.8 21.2
Negative 3.5 1.8
Attending GP
regularly for
screening (%)
95.2 94.9
Signiﬁcant difference between control and
intervention group
P< 0.02
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6difference in impact of the summary points was
seen when numerical information was given; in
four of the summary points moving subjects
away from screening and in one point towards
screening. Seventy-three percent of those inter-
viewed by telephone in the control group felt the
numerical information given to the intervention
group would have been useful and would have
aided their decision-making and over half of the
intervention group found the pictograms very or
quite helpful.
Strengths and weaknesses of the study
There are possible caveats surrounding this study.
First, the increased numberof subjects in the inter-
vention group with a family history of bowel
cancer could have biased the intervention group
towards screening and so lessened the potential
negative impact of the numerical information
they were given. Excluding all patients with a
family history of CRC reduced the percentage
wishing to be screened to 90.1% in the control
group and 80.1% in the intervention group but
the difference between control and intervention
groups did not reach statistical signiﬁcance (χ
2=
3.84, P =0.05). Second, although not signiﬁcant,
there was a trend to increased co-morbidity in
the control group which could have affected
their attitude to screening and without a larger
sample size we cannot exclude this possibility.
Finally, we chose to recruit our subjects from non-
gastroenterological hospital outpatient clinics and
GP surgeries. These subjects may already be
health-seekers and more likely to be in favour of
screening and therefore may not be representative
of all 60–70-year-olds. Nevertheless the compari-
son between the two groups stands and many
60–70-year-olds do attend clinics regularly.
The meta-analysis of CRC screening by
Moayyedi showed the relative risk of non-CRC
death in the screened group to be 1.02 (1.00–
1.04, P =0.015),
11 this increase exactly balancing
the reduced risk of CRC death in the screened
group. ‘Mortality substitution’ in the screened
group was also supported by Whynes et al. in
their analysis of deaths in the Nottingham
Trial.
16 Furthermore Moayyedi’s meta-analysis
found 16% of those in whom cancer was diag-
nosed by screening died within 2 years of unre-
lated causes or postoperative complications and
so may have been disadvantaged by earlier diag-
nosis. We were surprised that including data on
all cause mortality in our study was not viewed
negatively; indeed 68% said this numerical infor-
mation still made them want to be screened. Fear
of mortality from a speciﬁc illness or event, par-
ticularly cancer, may be a stronger drive to screen-
ing than concern about all-cause mortality or
mortality from non-speciﬁed events.
Strengths and weaknesses in relation to
other studies
The recent study by Smith et al. on the use of
decision aids in CRC screening has also made use
of natural frequencies and diagrams.
17 They
showed a reduction in screening participation in
the intervention group, but their study differs
Table 3
Table showing which summary point most inﬂuenced subjects’
decision on whether or not to be screened. Comparisons between
controls and intervention have been made excluding from the
intervention group total the nine subjects who put points 7 and 8 as
their most important point in decision-making as these choices
were not available to the control group
Summary point For each summary point numbers (%)
saying that this point was the most
important point in their decision-making
Control group
(n = 124)
Intervention
group (n = 117)
1 CRC mortality is
reduced by screening
81 (65.3) P= 0.0001 47 (40.2)
2 Polyp detection
prevents CRC
9 (7.3) P= 0.0006 25 (21.4)
3 CRC may be missed 5 (4.0) 6 (5.1)
4 Colonoscopy risky 7 (5.6) 6 (5.1)
5 Not all CRC treatable 5 (4.0) 7 (6.0)
6 Ease of use/privacy 9 (7.3) 9 (7.7)
79 /10 with +ve OB do
not have cancer
– 5 (4.3)
8 Screening does not
affect all-cause
mortality
– 4 (3.4)
Not sure/no speciﬁc
point
8 (6.4) 8 (6.8)
Signiﬁcant difference between control and intervention groups
P values refer to signiﬁcance of differences between control and
intervention group
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7from ours in that its focus was on adults with low
education and literacy standards and subjects
were not given ﬁgures on all cause mortality. Our
study suggests that all-cause mortality ﬁgures
need not be withheld from information leaﬂets for
fear of reducing uptake of CRC in the community.
The number wishing to be screened in our
control group (85%) is higher than the ﬁgure of
56% presenting for screening in the ﬁrst round of
the UK CRC programme.
18 However the ﬁgure of
56%foruptakeofCRCscreeningmatchesourques-
tionnaire return rate of 54%. We speculate that those
returning questionnaires on CRC screening may be
those who would be more likely to comply with
real-life screening programmes. This is supported
inour study by the83% returningthequestionnaire
whosaidtheywere generallypositive aboutscreen-
ing with only 2.7% overall against screening
(Table 1) and 95.4% said they ‘attend their GP
surgery for “check-ups” when invited’. An alterna-
tive explanation is that subjects faced with a
hypotheticalquestionnairerespondmorepositively
than when faced with the reality of obtaining and
testing their own stool and the anxiety of dealing
with a possible positive result.
Meaning of the study: possible
mechanisms and implications for
clinicians or policymakers
The difﬁcult question is how best to frame the
numerical information on screening. Natural fre-
quencies, as used in our study, and absolute risk
reduction are of relevance to the individual and
should be used in preference to relative risk
reduction and population-based ﬁgures as it is the
individual not the population that must decide
whether to be screened.
19 In their review,
Edwards et al. suggest that providing visual aids
and graphically representing information increase
the effectiveness of risk communication.
20 We
chose to illustrate numerical facts using pictograms
based on Paling’s risk charts and have used events
per 10,000 so that all events can be viewed against a
commondenominator.
1Canwebe sureevensothat
the subjects understood the information presented?
Intheinterventiongroupallbutonesubjecthadfull
understanding of the numerical information and
pictograms when interviewed by telephone and
Smith’s study shows that even in those with low
education and literacy standards the use of picto-
grams and numerical data improved understand-
ing. Sixty-two percent of our group found the
pictograms helpful or very helpful. Their wider
use in a standardized format may allow easier
quantiﬁcation of risk/beneﬁt for this as well as
other health interventions.
20,21
Our study shows that the provision of numeri-
cal data is welcomed and aids informed decision
without any overall impact on attitude to screen-
ing. Similar results were seen in a study by
Mathieu et al. with visual decision aids to help
decision-making for breast cancer screening.
22
Even if such data reduce uptake of screening
they should be included according to Jørgensen,
and rightly so, because concern for uptake
should never overrule concern for informed
consent. This contrasts with the view of the direc-
tor of the NHS cancer screening programme who
responded to a call to include numerical data in
the breast cancer screening leaﬂet by saying:
‘putting too much numerical information meant
women just put the leaﬂet down’.
23
All screening programmes carry a side-effect
burden of over-diagnosis and increased levels of
anxiety. An invitation for faecal occult blood
testing itself causes anxiety in 50% of subjects
which is severe in 5% even in those not called
for colonoscopy
24 and in the CRC programme
there are the potential risks and discomfort of
bowel preparation and colonoscopy in those
with positive faecal occult blood tests. The stan-
dard CRC leaﬂet does give numbers for colono-
scopy complications which in terms of total
numbers in the screened population are small
but not insigniﬁcant to those needing colono-
scopy. However the leaﬂet gives little other
patient-focused ﬁgures and in particular no
mention of lack of overall mortality beneﬁt.
12
Those responsible for promoting screening pro-
grammes are currently those who provide the
information to subjects and, as emphasized by
Jørgensen, therein lies a conﬂict of interest.
14
High participation rates are essential to ensure
the population beneﬁts of screening. Information
on the small absolute risk reduction achieved
by screening and the lack of evidence of overall
mortality reduction could deter subjects from
participating. Our study shows that this may not
be the case. The numerical and pictorial
information was welcomed by most subjects
J R Soc Med Sh Rep 2011;2:48. DOI 10.1258/shorts.2011.011030
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8and had no overall effect on their desire to be
screened.
In conclusion, our study suggests that provid-
ing numerical information, enhanced pictorially,
and focusing on the individual’s risks and beneﬁts
could enhance the credibility of the screening pro-
gramme without reducing the numbers screened.
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